Cytosorbents CTSO
NASDAQ CTSO
$5.45 +0.13 (+2.44%)
As of: Oct 21, 2026 · 3:35 PM EDT

Cytosorbents (CTSO) Restructuring Costs (2026)

Updated

Cytosorbents (CTSO) recorded Restructuring Costs of $300,000 in Q2 2026.

Analysis

Cytosorbents (CTSO) Restructuring Costs (2026) Analysis & Trends

For FY2025, Cytosorbents reported Restructuring Costs of $510,000.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.80 Bn 236.83 Bn 4.88 Bn
2 Abbott Laboratories 173.12 Bn 143.55 Bn 7.27 Bn
3 Danaher 163.20 Bn 147.01 Bn 3.61 Bn
4 Intuitive Surgical 152.66 Bn 132.09 Bn 1.96 Bn
5 Medtronic 118.77 Bn 84.02 Bn 6.34 Bn
6 Stryker 113.63 Bn 99.75 Bn 4.50 Bn
7 Boston Scientific 65.15 Bn 59.92 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.76 Bn 34.77 Bn 1.35 Bn
10 Cytosorbents 17.11 Mn -5.90 Mn 7.05 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 300,000.00
API Access

Cytosorbents Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=CTSO&period=max&api_key=YOUR_API_KEY